Non-Nicotine Agents for Smoking Cessation

• Status: Completed
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: US Department of Veterans Affairs; VA Office of Research and Development
• Treatments: Bupropion; Nicotine

Criteria

Inclusion Criteria:

• Readiness to set a quit date in the next two weeks,

• Current smoking of at least 15 cigarettes a day

Exclusion Criteria:

• Current untreated depression or receiving treatment for depression,

• History of seizures, major head injury, or other predisposition for seizures